In Response
- PMID: 40560771
- DOI: 10.1213/ANE.0000000000007624
In Response
Conflict of interest statement
Conflicts of Interest: The authors declare no conflicts of interest.
References
-
- Lasch A, Celik MO, Schäfer M, et al. Morphine and cardioprotection in a failing heart: friend, foe, or both? Anesth Analg. 2025;141:e75-e76
-
- Pan X, Guo C, Wang B, et al. The role of delta-opioid receptor in mediating the cardioprotective effects of morphine preconditioning via the JAK2/STAT3 pathway in a failing heart. Anesth Analg. 2025;141:706-717
-
- Jin SY, Huang J, Zhu HJ, et al. Remifentanil preconditioning confers cardioprotection via c-Jun NH2-terminal kinases and extracellular signal regulated kinases pathways in ex-vivo failing rat heart. Eur J Pharmacol. 2018;828:1–8.
-
- He SF, Jin SY, Wu H, et al. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3beta pathway independent of PI3K/Akt. Toxicol Appl Pharmacol. 2015;288:349–358.
-
- Dehe L, Shaqura M, Nordine M, et al. Chronic naltrexone therapy is associated with improved cardiac function in volume overloaded rats. Cardiovasc Drugs Ther. 2021;35:733–743.
Grants and funding
LinkOut - more resources
Full Text Sources
